glp 1 diabetes Could GLP-1 Receptor Agonists Help Prevent Infections in People with Diabetes? A Nationwide Study Says Yes—At Least for the Lungs and Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA GLP-1 receptor agonists and type

doi: 10.3389/FPHAR.2025.1517272/FULL 129 BonfioliGBRodellaLMetraMVizzardiE

The idea of regulating glucose levels through DPP-4 inhibition was initially conceived 25 years ago, paving the way for the development of different DPP-4 inhibitors and their widespread clinical utilization [38]

Serious adverse effects require careful monitoring: Pancreatitis : GLP-1 agonists carry warnings about acute pancreatitis risk

Why is this guidance necessary

Clinical trials have shown that orforglipron results in just over 15% body weight loss in adults with obesity, placing it on par with that seen with Wegovy, but significantly lower than the 21% weight loss seen with Mounjaro

At the 1 He concluded by noting a draft statement from the upcoming European Society for Medical Oncology (ESMO) guidelines